Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Altimmune Inc’s current trading price is -61.25% away from its 52-week high, while its distance from the 52-week low is 49.14%. The stock’s price range over this period has fluctuated between $2.90 and $11.16. The company, operating within the financial sector, had a trading volume of approximately 3.29 million for the day, which was noticeably lower than the average daily share volume of 5.6 million over the last 3 months.
The stock of Altimmune Inc (ALT) is currently priced at $4.32. In the last session, the stock climbed significantly, topping out at $28.0 after opening at $4.36. The day’s lowest price was $6.0 before the stock closed at $4.2.
Altimmune Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $11.16 on 11/13/24 and a low of $2.90 for the same time frame on 06/26/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Altimmune Inc (ALT) has experienced a quarterly decline of -10.82% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 350.79M and boasts a workforce of 59 employees.
Altimmune Inc: What Analysts Are Saying
As of right now, 5 analysts are rating Altimmune Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.30, with a change in price of -2.09. Similarly, Altimmune Inc recorded 4,522,628 in trading volume during the last 100 days, posting a change of -32.58%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ALT stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
ALT Stock Stochastic Average
Today’s raw stochastic average for Altimmune Inc over the last 50 days is 29.57%.This indicates a increase from the raw stochastic average of the past 20 days, which was 29.57%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 26.76% and 25.28%, respectively.
ALT Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -31.13% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -36.68%. Over the past 30 days, the price of ALT has leaped by -38.13%. And in the last five days, it has surged by 3.47%.
